Cargando…
Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.
The influence of liver biochemistry tests on epirubicin pharmacokinetics has been investigated in 52 women with advanced breast cancer, 27 of whom had radiologically proven liver metastases. Patients received epirubicin 12.5-120 mg m-2 given as an i.v. bolus. Epirubicin levels were measured by HPLC...
Autores principales: | Twelves, C. J., Dobbs, N. A., Michael, Y., Summers, L. A., Gregory, W., Harper, P. G., Rubens, R. D., Richards, M. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977407/ https://www.ncbi.nlm.nih.gov/pubmed/1419619 |
Ejemplares similares
-
Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.
por: Twelves, C. J., et al.
Publicado: (1989) -
What is the effect of adjusting epirubicin doses for body surface area?
por: Dobbs, N. A., et al.
Publicado: (1998) -
Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?
por: Dobbs, N. A., et al.
Publicado: (1998) -
Epirubicin
por: Cornish, J., et al.
Publicado: (1988) -
Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.
por: Johnson, P. J., et al.
Publicado: (1992)